334 related articles for article (PubMed ID: 24269170)
1. Neurofibromatosis type 1 associated with moyamoya syndrome in children.
Duat-Rodríguez A; Carceller Lechón F; López Pino MÁ; Rodríguez Fernández C; González-Gutiérrez-Solana L
Pediatr Neurol; 2014 Jan; 50(1):96-8. PubMed ID: 24269170
[TBL] [Abstract][Full Text] [Related]
2. Moyamoya syndrome associated with neurofibromatosis Type 1: perioperative and long-term outcome after surgical revascularization.
Koss M; Scott RM; Irons MB; Smith ER; Ullrich NJ
J Neurosurg Pediatr; 2013 Apr; 11(4):417-25. PubMed ID: 23373626
[TBL] [Abstract][Full Text] [Related]
3. 'Moya' than meets the eye: neurofibromatosis type 1 associated with Moyamoya syndrome.
Tan RM; Chng SM; Seow WT; Wong J; Lim CC
Singapore Med J; 2008 Apr; 49(4):e107-9. PubMed ID: 18418511
[TBL] [Abstract][Full Text] [Related]
4. Moyamoya syndrome associated with neurofibromatosis type 1 in a pediatric patient.
Serafini NB; Serafini CB; Vinhas AS; Godinho MB
An Bras Dermatol; 2017; 92(6):870-873. PubMed ID: 29364453
[TBL] [Abstract][Full Text] [Related]
5. Cerebrovascular abnormalities in a population of children with neurofibromatosis type 1.
Rosser TL; Vezina G; Packer RJ
Neurology; 2005 Feb; 64(3):553-5. PubMed ID: 15699396
[TBL] [Abstract][Full Text] [Related]
6. Moyamoya syndrome and neurofibromatosis type 1.
Vargiami E; Sapountzi E; Samakovitis D; Batzios S; Kyriazi M; Anastasiou A; Zafeiriou DI
Ital J Pediatr; 2014 Jun; 40():59. PubMed ID: 24952383
[TBL] [Abstract][Full Text] [Related]
7. Progression of disease in unilateral moyamoya syndrome.
Smith ER; Scott RM
Neurosurg Focus; 2008; 24(2):E17. PubMed ID: 18275294
[TBL] [Abstract][Full Text] [Related]
8. Cerebral vasculopathy in children with neurofibromatosis type 1.
Ghosh PS; Rothner AD; Emch TM; Friedman NR; Moodley M
J Child Neurol; 2013 Jan; 28(1):95-101. PubMed ID: 22532547
[TBL] [Abstract][Full Text] [Related]
9. Surgical Treatment for Patients with Moyamoya Syndrome and Type 1 Neurofibromatosis.
Porras JL; Yang W; Garzon-Muvdi T; Xu R; Blakeley J; Belzberg A; Caplan JM; Khalid S; Colby GP; Coon AL; Tamargo RJ; Ahn ES; Huang J
World Neurosurg; 2017 Mar; 99():19-25. PubMed ID: 27876659
[TBL] [Abstract][Full Text] [Related]
10. Moyamoya syndrome associated with neurofibromatosis type I in a pediatric patient.
Darrigo Júnior LG; Valera ET; Machado Ade A; Santos AC; Scrideli CA; Tone LG
Sao Paulo Med J; 2011 Mar; 129(2):110-2. PubMed ID: 21603789
[TBL] [Abstract][Full Text] [Related]
11. Moyamoya syndrome in children with neurofibromatosis type 1: Italian-French experience.
Santoro C; Di Rocco F; Kossorotoff M; Zerah M; Boddaert N; Calmon R; Vidaud D; Cirillo M; Cinalli G; Mirone G; Giugliano T; Piluso G; D'Amico A; Capra V; Pavanello M; Cama A; Nobili B; Lyonnet S; Perrotta S
Am J Med Genet A; 2017 Jun; 173(6):1521-1530. PubMed ID: 28422438
[TBL] [Abstract][Full Text] [Related]
12. Ophthalmic artery ischemic syndrome associated with neurofibromatosis and moyamoya syndrome.
Witmer MT; Levy R; Yohay K; Kiss S
JAMA Ophthalmol; 2013 Apr; 131(4):538-9. PubMed ID: 23430230
[No Abstract] [Full Text] [Related]
13. Neurofibromatosis type 1 association with moyamoya disease.
Koc F; Yerdelen D; Koc Z
Int J Neurosci; 2008 Aug; 118(8):1157-63. PubMed ID: 18576213
[TBL] [Abstract][Full Text] [Related]
14. [Neurofibromatosis associated with moyamoya arteriopathy and fusiform aneurysm: case report].
Siqueira Neto JI; Silva GS; De Castro JD; Santos AC
Arq Neuropsiquiatr; 1998 Dec; 56(4):819-23. PubMed ID: 10029888
[TBL] [Abstract][Full Text] [Related]
15. Association between moyamoya syndrome and the RNF213 c.14576G>A variant in patients with neurofibromatosis Type 1.
Phi JH; Choi JW; Seong MW; Kim T; Moon YJ; Lee J; Koh EJ; Ryu SK; Kang TH; Bang JS; Oh CW; Park SS; Lee JY; Wang KC; Kim SK
J Neurosurg Pediatr; 2016 Jun; 17(6):717-22. PubMed ID: 26849809
[TBL] [Abstract][Full Text] [Related]
16. Moyamoya syndrome after radiation therapy for optic pathway glioma: case report.
Serdaroğlu A; Simşek F; Gücüyener K; Oğuz A; Karadeniz C; Balibey M
J Child Neurol; 2000 Nov; 15(11):765-7. PubMed ID: 11108514
[TBL] [Abstract][Full Text] [Related]
17. Moyamoya Vasculopathy in PHACE Syndrome: Six New Cases and Review of the Literature.
Tortora D; Severino M; Accogli A; Martinetti C; Vercellino N; Capra V; Rossi A; Pavanello M
World Neurosurg; 2017 Dec; 108():291-302. PubMed ID: 28887276
[TBL] [Abstract][Full Text] [Related]
18. Discovery of asymptomatic moyamoya arteriopathy in pediatric syndromic populations: radiographic and clinical progression.
Lin N; Baird L; Koss M; Kopecky KE; Gone E; Ullrich NJ; Scott RM; Smith ER
Neurosurg Focus; 2011 Dec; 31(6):E6. PubMed ID: 22133171
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous presentation of malignant peripheral nerve sheath tumor and moyamoya disease associated with neurofibromatosis type 1 in a child.
Yoo SY; Hwang SM; Lee MK; Jo DS; Hwang PH
Turk J Pediatr; 2015; 57(2):202-5. PubMed ID: 26690608
[TBL] [Abstract][Full Text] [Related]
20. Systemic hypertension followed by insidious stroke in a 12-year-old boy with childhood neurofibromatosis type 1 presenting with renal and cerebral artery vasculopathy.
Lee ML; Chang TM; Yang RC; Yang AD; Chen M
Turk J Pediatr; 2019; 61(4):629-634. PubMed ID: 31990487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
